Search results
Prevention and treatment protocols for COVID, Flu and RSV. The protocols and treatment guidelines on this page represent our recommended approaches based on the best and most recent literature and research.
- About FLCCC
Support Us Our work would not be possible without you! Help...
- Long COVID
I-RECOVER Post-Vaccine Treatment Guide Download I-RECOVER...
- I-Care
Higher doses (0.6 mg/kg) may be required: in regions with...
- Math+ Covid Hospital Treatment
MATH+ is the hospital treatment protocol for COVID-19,...
- Eat Well
The FLCCC "Eat Well" guide details how fasting induces...
- Recovery
Recovery protocols for managing symptoms from long COVID and...
- Prevention
Prevention protocols created by FLCCC. Boost your immune...
- Cart
FLCCC’s learning programs let you stream video lectures,...
- About FLCCC
30 mar 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the...
Higher doses (0.6 mg/kg) may be required: in regions with more aggressive variants; if treatment starts on or after 5 days of symptoms; in patients in advanced stage of the disease or who have extensive risk factors (i.e., older age, obesity, diabetes, etc.) Table 1. How to calculate ivermectin dose.
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf ….
14 gru 2022 · Given the wide availability and low cost of ivermectin and that the dosage used in the trial appeared to be safe, such treatment effects could be an important benefit for high-risk patients who...
17 cze 2021 · A concentration dependent antiviral effect of ivermectin in COVID-19 was identified, with significant reductions in SARS-CoV-2 viral load in respiratory secretions among patients achieving high systemic ivermectin concentration compared to untreated controls.
1 sie 2024 · Two authors (VP, AVH) independently selected studies and discrepancies were resolved with discussion. We included RCTs evaluating effects of oral ivermectin on clinical, non-clinical and safety outcomes in non-hospitalized or ambulatory COVID-19 patients, at early stage of disease.